Böhme Ines, Schönherr Roland, Eberle Jürgen, Bosserhoff Anja Katrin
Institute of Biochemistry, Emil Fischer Center, Friedrich-Alexander-University of Erlangen-Nürnberg, Erlangen, Germany.
Institute of Biochemistry and Biophysics, Friedrich Schiller University Jena and Jena University Hospital, Jena, Germany.
Rev Physiol Biochem Pharmacol. 2021;181:269-374. doi: 10.1007/112_2020_17.
Recent research has revealed that ion channels and transporters can be important players in tumor development, progression, and therapy resistance in melanoma. For example, members of the ABC family were shown to support cancer stemness-like features in melanoma cells, while several members of the TRP channel family were reported to act as tumor suppressors.Also, many transporter proteins support tumor cell viability and thus suppress apoptosis induction by anticancer therapy. Due to the high number of ion channels and transporters and the resulting high complexity of the field, progress in understanding is often focused on single molecules and is in total rather slow. In this review, we aim at giving an overview about a broad subset of ion transporters, also illustrating some aspects of the field, which have not been addressed in detail in melanoma. In context with the other chapters in this special issue on "Transportome Malfunctions in the Cancer Spectrum," a comparison between melanoma and these tumors will be possible.
最近的研究表明,离子通道和转运蛋白可能在黑色素瘤的肿瘤发生、进展及治疗耐药性方面发挥重要作用。例如,ABC家族成员被证明可支持黑色素瘤细胞中类似癌症干细胞的特性,而据报道,瞬时受体电位(TRP)通道家族的几个成员可作为肿瘤抑制因子。此外,许多转运蛋白可维持肿瘤细胞的活力,从而抑制抗癌治疗诱导的细胞凋亡。由于离子通道和转运蛋白数量众多,导致该领域极为复杂,因此在理解方面的进展往往集中在单个分子上,总体进展相当缓慢。在本综述中,我们旨在对广泛的离子转运蛋白子集进行概述,同时也阐述该领域中一些在黑色素瘤方面尚未详细探讨的内容。结合本期关于“癌症谱系中的转运体功能障碍”特刊的其他章节,将有可能对黑色素瘤与这些肿瘤进行比较。